Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Scruggstyleon Dec 19, 2015 9:31pm
92 Views
Post# 24398745

RE:RE:RE:RE:Pineapple

RE:RE:RE:RE:Pineapple
pineapple1 wrote: sunshine, the blended rate is in the 7% range, and they've estimated revenue growth to be in the 8 - 10% 2016 - 2018.


Pineapple,

I'm afraid that you didn't actually provide much, in substance, to rebut.  You know, as well as the rest of us, that (between Concordia and AMCo) several product and corporate acquisitions have been made over the past 12 months, branch offices have opened in various regions of the world, new distribution and other business relationships have been entered into, AND that the impact of these endeavors, on the operating results of the new, combined entity (as well as any financial synergies realized from our most recent business combination), are simply unknown, at this time.  Growth is a relative concept, which reqires a comparative benchmark against which to measure.  We currently have no such benchmark.  You are going to have to wait for at least a couple of quarters' results (if not a year's) before I would even consider your questioning of the company's growth prospects as being legitimate, if at all sincere.

For now, we do have the 2016 guidance provided by management, our knowledge of the existing products/markets, and the consensus of various analysts at our disposal.  Our assessment of risk is reflected in the range of multiples that we choose to apply to our estimates of future earnings or cash flows.  I am using a conservative 10-12X multiple in my own decision making, I am not aware of any more credible estimate of 2016 earnings than that provided by the company's management, and I am satisfied with the prediction of high-single-digit growth, over the next several years.  In addition, I don't mind waiting for results.  What else would I do with the money, anyways?  Go ahead and short, . . or trade.  If I am right, I'll be waiting for both of you (and fdfd12) at the finish line.
<< Previous
Bullboard Posts
Next >>